In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells

This publication has 122 references indexed in Scilit:

• Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease
  EMBO Molecular Medicine, 2012
• A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
  Neuron, 2011
• Introduction to Induced Pluripotent Stem Cells: Advancing the Potential for Personalized Medicine
  World Neurosurgery, 2011
• Development of Histocompatible Primate‐Induced Pluripotent Stem Cells for Neural Transplantation
  Stem Cells, 2011
• Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid
  Molecular and Cellular Neuroscience, 2010
• Genetic Analysis of Pathways to Parkinson Disease
  Neuron, 2010
• Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics
  Trends in Neurosciences, 2009
• Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease
  Human Mutation, 2008
• Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
  Cell, 2006
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
  Nature, 1993